Nature of the Organization and Business (Details) |
1 Months Ended | |
|---|---|---|
|
Sep. 17, 2021
USD ($)
$ / shares
shares
|
Dec. 31, 2021
USD ($)
|
|
| Nature of the Organization and Business (Details) [Line Items] | ||
| Offering costs | $ 3,445,200 | |
| Underlying fees and expense | 2,137,800 | |
| Costs related to initial public offering | $ 1,307,400 | |
| Operating bank accounts | $ 52,966,706 | |
| Working capital | $ 52,853,177 | |
| IPO [Member] | ||
| Nature of the Organization and Business (Details) [Line Items] | ||
| Number of amount (in Shares) | shares | 4,800,000 | |
| Price per unit (in Dollars per share) | $ / shares | $ 5 | |
| Total amount | 24,000,000 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Number of amount. No definition available.
|
| X | ||||||||||
- Definition Costs incurred during the period, such as those relating to general administration and policy maintenance that do not vary with and are not primarily related to the acquisition or renewal of insurance contracts. No definition available.
|
| X | ||||||||||
- Definition Working capital. No definition available.
|
| X | ||||||||||
- Definition Total costs of sales and operating expenses for the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The cumulative amount of offering costs allocated to the general partner. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The number of units in a real estate property owned as of the balance sheet date. No definition available.
|
| X | ||||||||||
- Definition Amount of short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates, classified as other. Excludes cash and cash equivalents within disposal group and discontinued operation. No definition available.
|
| X | ||||||||||
- Definition Per share amount received by subsidiary or equity investee for each share of common stock issued or sold in the stock transaction. No definition available.
|
| X | ||||||||||
- Details
|